AKAM vs ANAB · P/E 27, rev $2.17B vs rev $234.6M
Akamai Technologies Inc (AKAM) versus AnaptysBio Inc (ANAB) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. ANAB currently screens at market cap $1.62B.
Not investment advice. Open the AKAM and ANAB stock pages for the full models.
Not investment advice.